Fei‐Ran Gong
Nankai University(CN)
Publications by Year
Research Areas
Beetle Biology and Toxicology Studies, Inflammatory Biomarkers in Disease Prognosis, Virus-based gene therapy research, Multiple Myeloma Research and Treatments, CAR-T cell therapy research
Most-Cited Works
- → Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer(2015)123 cited
- → Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo(2017)115 cited
- → Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma(2022)73 cited
- → TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells(2017)69 cited
- → Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer(2015)67 cited
- → The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3′-UTR(2011)64 cited
- → Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin(2013)60 cited
- → The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair(2018)52 cited
- → PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKα and sustained activation of the NF-κB pathway(2011)51 cited
- → Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer(2017)51 cited